Voyager Therapeutics

About Voyager Therapeutics

Voyager Therapeutics develops life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of advanced Parkinson’s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Huntington’s disease, Friedreich’s ataxia, neurodegenerative diseases related to defective or excess aggregation of tau protein in the brain including Alzheimer’s disease, and severe, chronic pain.


Business Development Intern

June 2020 Cambridge, MA
“The people!”

Neuroscience Intern

May 2019 - August 2019 Cambridge, MA
“I enjoyed the working environment and company culture at Voyager. Everyone on the research team was super helpful and supportive. I really appreciated the opportunity to do my own study and the independence it offered. ”
See All